Bouquets and Brickbats for FDA OK of Alzheimer's Drug Aduhelm
June 15th 2021The Alzheimer's Association praises the approval but not the price tag. A Harvard Medical School professor who resigned from an FDA advisory committee says the OK "was probably the worst approval decision in recent U.S. history" in his resignation letter.